Literature DB >> 11436947

Peroxiredoxin in bovine ocular tissues: immunohistochemical localization and in situ hybridization.

A K Singh1, H Shichi.   

Abstract

Peroxiredoxins are widely distributed in nature and constitute a molecular family of antioxidant enzymes which decompose hydrogen peroxide and alkyl hydroperoxides. We have previously characterized a peroxiredoxin from bovine ciliary body and deduced its amino acid sequence from analysis of cDNA clones encoding the protein. In this work, we investigated the immunolocalization of this novel antioxidant enzyme and its mRNA expression in bovine eye tissues. High levels of immunoreactivity and mRNA for the enzyme were detected in corneal epithelium. Distinct immunoreactivity and mRNA expression for peroxiredoxin were also detected in uveal tissues, some of the retinal cell layers and ocular vasculature.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11436947     DOI: 10.1089/108076801750295308

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  4 in total

Review 1.  Review of application of mass spectrometry for analyses of anterior eye proteome.

Authors:  Sherif Elsobky; Ashley M Crane; Michael Margolis; Teresia A Carreon; Sanjoy K Bhattacharya
Journal:  World J Biol Chem       Date:  2014-05-26

Review 2.  Oxidative stress, lens gap junctions, and cataracts.

Authors:  Viviana M Berthoud; Eric C Beyer
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

3.  Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy.

Authors:  Ula V Jurkunas; Ian Rawe; Maya S Bitar; Cheng Zhu; Deshea L Harris; Kathryn Colby; Nancy C Joyce
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

4.  Life-time expression of the proteins peroxiredoxin, beta-synuclein, PARK7/DJ-1, and stathmin in the primary visual and primary somatosensory cortices in rats.

Authors:  Michael R R Böhm; Harutyun Melkonyan; Solon Thanos
Journal:  Front Neuroanat       Date:  2015-03-04       Impact factor: 3.856

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.